Literature DB >> 20670658

Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.

A Ermel1, B Qadadri, A Morishita, I Miyagawa, G Yamazaki, B Weaver, W Tu, Y Tong, M Randolph, H Cramer, D Brown.   

Abstract

Three methods for the detection of HPV DNA were compared in cervical cytologic specimens: the Digene Hybrid Capture II Assay (HC), the Roche Linear Array HPV Genotyping Assay (LA) and the Kurabo GeneSquare Microarray (GS). The main goals of the study were to correlate cytology with HPV detection and to determine agreement between assay pairs for HPV detection. Thin-prep Pap smears were performed and supernates were tested by HC, LA, and GS. For specimens reacting with the HPV 52/33/35/58 probe in the LA assay, type-specific PCR was performed for HPV types 52, 33, 35, or 58. Binomial proportions and kappa coefficients were calculated for agreement between assays. Cytology results and supernatant were available for 202 subjects. HPV detection increased with worsening cytologic abnormality in all three assays. For all cytologic groups, LA and GS detected more HPV (all and oncogenic) than HC. However, for detection of oncogenic HPV types represented in all three assays, differences between assays were less pronounced. The highest agreement was between LA and GS. In four of 12 specimens reacting with the HPV 52/33/35/58 probe in the LA assay but deemed HPV 52-LA-negative using an algorithm provided by the manufacturer, the presence of HPV 52 was confirmed using type-specific HPV 52 PCR. All four of these specimens were also GS-positive for HPV 52. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20670658     DOI: 10.1016/j.jviromet.2010.07.016

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  13 in total

1.  Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction.

Authors:  Jessica A Kahn; Darron R Brown; Lili Ding; Lea E Widdice; Marcia L Shew; Susan Glynn; David I Bernstein
Journal:  Pediatrics       Date:  2012-07-09       Impact factor: 7.124

2.  Reduction of HPV infections through vaccination among at-risk urban adolescents.

Authors:  Teresa Cummings; Gregory D Zimet; Darron Brown; Wanzhu Tu; Ziyi Yang; J Dennis Fortenberry; Marcia L Shew
Journal:  Vaccine       Date:  2012-06-28       Impact factor: 3.641

3.  Can clinical tests help monitor human papillomavirus vaccine impact?

Authors:  Elissa Meites; Carol Lin; Elizabeth R Unger; Martin Steinau; Sonya Patel; Lauri E Markowitz; Susan Hariri
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

4.  Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer.

Authors:  Laura Ortega-Cervantes; Adriana Aguilar-Lemarroy; Aurora Elizabeth Rojas-García; Briscia Socorro Barrón-Vivanco; Verónica Vallejo-Ruiz; David Cantú-De León; Yael Yvette Bernal Hernández; Armando Jáuregui-Martínez; Irma Martha Medina-Díaz
Journal:  Int J Health Sci (Qassim)       Date:  2016-07

Review 5.  Cutaneous squamous cell carcinoma and human papillomavirus: is there an association?

Authors:  Bishr Aldabagh; Jorge Gil C Angeles; Adela R Cardones; Sarah T Arron
Journal:  Dermatol Surg       Date:  2012-08-28       Impact factor: 3.398

6.  Association of Chlamydia trachomatis infection with redetection of human papillomavirus after apparent clearance.

Authors:  Marcia L Shew; Aaron C Ermel; Bree A Weaver; Yan Tong; Wanzhu Tu; Laura M Kester; Cheryl Denski; J D Fortenberry; Darron R Brown
Journal:  J Infect Dis       Date:  2013-08-02       Impact factor: 5.226

7.  Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.

Authors:  Zhang Sheng; Hiroshi Minato; Toshiyuki Sasagawa; Satoko Nakada; Eriko Kinoshita; Nozomu Kurose; Takayuki Nojima; Satoru Makinoda
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

8.  Validation of a diagnostic microarray for human papillomavirus: coverage of 102 genotypes.

Authors:  Sarah Tuttleton Arron; Peter Skewes-Cox; Phong H Do; Eric Dybbro; Maria Da Costa; Joel M Palefsky; Joseph L Derisi
Journal:  J Nucleic Acids       Date:  2011-05-18

9.  Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer.

Authors:  Shun-Ichi Isa; Yu Kurahara; Satomi Yamamoto; Akihiro Tamiya; Naoki Omachi; Kazuhiro Asami; Kyoichi Okishio; Tomoki Utsumi; Norimasa Ito; Hyung-Eun Yoon; Akihide Matsumura; Shinji Atagi; Tomoya Kawaguchi
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

10.  Sensitive HPV genotyping based on the flow-through hybridization and gene chip.

Authors:  Pingping Tao; Weiping Zheng; Yungen Wang; Mei-Lu Bian
Journal:  J Biomed Biotechnol       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.